XRPBullunverifiable
Stock Moe“Do not be surprised to see the shorts pile in and then get burned on a short squeeze. You heard it here first.”
Thesis at the time
MixedThe host is disappointed that the Clarity Act failed in the Senate (49-50) and expects meaningful market-structure legislation to be delayed until 2027 or later, which he says is weighing on XRP's price. Despite the setback, he says the drop was largely priced in already and he personally is holding rather than selling, and he expects a possible short squeeze if traders overreact to the news.
Key arguments
- The Clarity Act failed 49-50, 11 votes short of the 60 needed, with zero Democrats voting yes
- Most likely path forward is reintroduction in the new Congress starting January 2027, or possibly attached to the December 11th funding bill
- The market had already priced in the bill's failure before the vote, so the initial reaction may be overblown
- XRP is not currently classified as a security due to an existing court ruling, and multiple XRP ETF filings remain pending
Counter-arguments acknowledged
- Legislation could be delayed until 2030 per Senator Lummis if the current window is missed
- A break below the $1 psychological level would signal the trend is going the wrong direction
Hedges and caveats (from the video)
- Host expresses personal frustration but acknowledges uncertainty about timeline
- Notes that SEC and CFTC could provide regulatory clarity within 2.5 years regardless of Clarity Act passage
- Acknowledges this is a setback but not a permanent failure
- Video contains promotional content for paid services and newsletter
The call
- Date said
- Sep 16, 2026
- Price at prediction
- $1.30
- Confidence
- medium
- Specificity
- vague
How it resolved
- Status
- unverifiable
Why this resolved this way(resolution audit)
Full rules: docs/resolution-spec.md.
Confidence Reasoning
Strong personal-stake language ('you heard it here first') suggests conviction, but there is no specific price target or timeframe, and the call is somewhat speculative.